Prostaglandin Receptor
Prostaglandin receptor, a sub-family of cell surface seven-transmembrane receptors, are the G-protein-coupled receptors. There are currently ten known prostaglandin receptors on various cell types. Prostaglandins bind to a subfamily of cell surface seven-transmembrane receptors, G-protein-coupled receptors. These receptors are named: DP1-2-DP1, DP2 receptors, EP1-4-EP1, EP2, EP3, EP4 receptors, FP-FP, IP1-2-IP1, IP2 receptors, TP-TP receptor. The prostaglandins are a group of hormone-like lipid compounds that are derived enzymatically from fatty acids and have important functions in the animalbody. There are currently ten known prostaglandin receptors on various cell types.
Prostaglandin Receptor Isoform Specific Products
All Product Categories
-
Prostaglandin Receptor Inhibitors
(171)
View all products
-
Prostaglandin Receptor Agonists
(193)
View all products
-
Prostaglandin Receptor Antagonists
(178)
View all products
-
Prostaglandin Receptor Activators
(25)
View all products
-
Prostaglandin Receptor Modulators
(4)
View all products
-
Prostaglandin Receptor Inducers
(2)
View all products
-
Prostaglandin Receptor Degrader
(1)
View all products
-
Prostaglandin Receptor Controls
(49)
View all products
-
Prostaglandin Receptor Ligands
(3)
View all products
-
Prostaglandin Receptor Related Products (766)
Related Products (766)
-
Antibodies (2)
-
Prostaglandin Receptor Isoform Comparison
-
Bimatoprost acid
0 ImagesSynonyms: 17-Phenyl trinor PGF2αBimatoprost acid (17-Phenyl trinor PGF2α), the acid hydrolysis product of Bimatoprost (HY-B0191), is a potent agonist of prostaglandin FP receptor.
-
Tranilast sodium
0 ImagesSynonyms: MK-341 sodium; SB 252218 sodiumTranilast sodium (MK-341 sodium) acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM). Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells.
-
Iloprost-d4
0 ImagesCat. No.: HY-A0096SCAS No.: 1035094-10-0Iloprost-d4 (Ciloprost-d4) is the deuterium labeled Iloprost. Iloprost (ZK 36374) is a synthetic analogue of prostacyclin PGI2.
-
15(R)-Prostaglandin D2
0 ImagesSynonyms: 15R-PGD215(R)-Prostaglandin D2 is a potential prostatic hormone DP(2) receptor (Prostaglandin Receptor) agonist with anti-inflammatory activity. 15(R)-Prostaglandin D2 increases actin polymerization in human eosinophils and increases cAMP levels in platelets.
-
Seratrodast (Standard)
0 ImagesSynonyms: AA 2414 (Standard)Seratrodast (Standard) is the analytical standard of Seratrodast. This product is intended for research and analytical applications. Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity.
-
Cyanidin Chloride (Standard)
0 ImagesCyanidin Chloride (IdB 1027) (Standard) is the analytical standard of Cyanidin Chloride (IdB 1027). This product is intended for research and analytical applications. Cyanidin Chloride (IdB 1027) is an orally active antioxidant and enzyme inhibitor. Cyanidin Chloride has IC50 values of 90 μM and 60 μM against PGHS-1 and PGHS-2, respectively. Cyanidin Chloride exhibits excellent antioxidant and anti-inflammatory activities, scavenges free radicals, inhibits lipid peroxidation, and protects DNA from cleavage. Cyanidin Chloride can be used in the research of inflammatory diseases.
-
Sulotroban
0 ImagesSynonyms: SKF-95587; BM-13177Sulotroban (SKF-95587; BM-13177) is a selective antagonist for thromboxane A2 receptor (TXA2 Receptor). Sulotroban exhibits inhibitory activity against carbocyclic thromboxane A2- and endoperoxide-induced vasoconstrictor. Sulotroban inhibits platelets aggregation.
-
8-Isoprostaglandin E2
0 ImagesSynonyms: iPE2-III8-Isoprostaglandin E2 (iPE2-III) is a member of the isoprostane class of prostanoids. 8-Isoprostaglandin E2 acts at the receptor for thromboxane A2 (the TP) in vivo to induce vasoconstriction and platelet aggregation. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
-
Treprostinil diethanolamine (Standard)
0 ImagesCat. No.: HY-B0813RCAS No.: 830354-48-8Synonyms: UT-15C (Standard)Geniposide (Standard) is the analytical standard of Geniposide. This product is intended for research and analytical applications. Geniposide is an iridoid glucoside extracted from Gardenia jasminoidesEllis fruits; exhibits a varity of biological activities such as anti-diabetic, antioxidative, antiproliferative and neuroprotective activities.
-
TP-18
0 ImagesCat. No.: HY-184555TP-18 is a potent and orally active dual EP2/EP4 antagonist with IC50 values of 9.5 nM (EP2) and 3.3 nM (EP4). TP-18 effectively depletes a highly immunosuppressive VSIG4high tumor-associated macrophage (TAM) subset and enhances cytotoxic CD8+ T cell-mediated colorectal cancer (CRC) tumor elimination. TP-18 dampens the expression of VSIG4 by blunting EP2/EP4-Gαs-PKA signaling. TP-18 enhances the sensitivity of anti-PD-1 therapy in CRC mouse models and in patient-derived tumor immune organoids. TP-18 can be used to study colorectal cancer.
-
Sepetaprost
0 ImagesCat. No.: HY-128538CAS No.: 1262873-06-2Synonyms: ONO-9054Sepetaprost (ONO-9054) is a dual agonist of the prostaglandin E3 receptor and prostaglandin F receptor. Sepetaprost reduces intraocular pressure in animal models. Sepetaprost is applicable for research on ocular hypertension and open-angle glaucoma.
-
BAY-6672
0 ImagesCat. No.: HY-142658CAS No.: 2247517-53-7BAY-6672, a chemical probe, is a potent and selective human Prostaglandin F (FP) receptor antagonist with an IC50 value of 11 nM.
-
Laropiprant sodium
0 ImagesCat. No.: HY-50175ACAS No.: 572874-50-1Synonyms: MK-0524 sodium
-
MK-8318
0 ImagesCat. No.: HY-112604CAS No.: 1416581-40-2MK-8318 is a potent and selective CRTh2 receptor antagonist with a Ki of 5.0 nM.
-
CP-432
0 ImagesCat. No.: HY-119236CAS No.: 431990-08-8Synonyms: CP-734432CP-432 (CP-734432) is a EP4 receptor agonist with an IC50 of 2 nM for human sources, 8 nM for canine sources, and an EC50 of 1 nM for human sources. CP-432 stimulates cAMP production and activates β-lactamase (β-lactamase) activity via the cAMP response element signaling pathway. CP-432 is applicable to research related to glaucoma.
-
17-Trifluoromethylphenyl trinor prostaglandin F2α ethyl amide
0 ImagesCat. No.: HY-163376CAS No.: 1621369-73-0Synonyms: 17-CF3PTPG2α EA17-Trifluoromethylphenyl trinor prostaglandin F2α ethyl amide (compound 17-CF3PTPG2α EA) is a lipophilic analog of 17-trifluoromethylphenyl trinor PGF2α.
-
(+)-JJ-450
0 ImagesCat. No.: HY-403733BCAS No.: 1998094-24-8(+)-JJ-450 is a non-competitive antagonist targeting the androgen receptor (AR) that inhibits AR nuclear localization and transcriptional activity in the absence of androgen. (+)-JJ-450 is less active than (-)-JJ-450 (HY-403733A) in inhibiting prostate-specific antigen (PSA) expression in LN95 cells, possibly because (+)-JJ-450 targets the ligand binding domain (LBD) of AR. (+)-JJ-450 inhibits the transcriptional activity of AR and its splice variants (e.g., ARv7) by promoting the degradation of unliganded AR in the nucleus and reducing the binding of AR to androgen response elements (AREs). (+)-JJ-450 can be used in castration-resistant prostate cancer (CRPC) studies that are resistant to enzalutamide (MDV3100) (HY-70003).
-
SC 34301
0 ImagesCat. No.: HY-105052CAS No.: 81026-63-3Synonyms: EnisoprostSC 34301 (Enisoprost) is a potent and orally active PGE1 analog. SC 34301 significantly reduces bacterial translocation and improves survival for burned mice.
-
9-Keto-latanoprost
0 ImagesCat. No.: HY-159704CAS No.: 141074-06-89-keto latanoprost is a derivative of the F-prostaglandin (FP) receptor agonist Latanoprost (HY-B0577).
-
L 377202
0 ImagesCat. No.: HY-106195CAS No.: 207395-85-5L 377202 is a peptide-drug conjugate (PDC). L 377202 consists of Doxorubicin (HY-15142A) and a prostate-specific antigen (PSA)-hydrolyzable peptide. L 377202 demonstrates strong inhibitory effects on PSA-secreting prostate cancer cells. L 377202 is promising for research of prostate cancer.
